wegovy women's obesity data

Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congre

Avoid 7 Mistakes in Women’s Obesity Treatment With Wegovy

To avoid the seven common mistakes in women’s obesity treatment with Wegovy, clinicians should personalize dosing, start therapy early, monitor gastrointestinal tolerance, combine GLP-1 therapy with behavioral counseling, and stay aware of FDA compounding restrictions. Data unveiled this week shows that women on Wegovy® gained 8% of body weight